Why is Wave Life Sciences Ltd. ?
- DEBT-EQUITY RATIO (HY) Highest at -98.57 %
- RAW MATERIAL COST(Y) Grown by 107.14% (YoY)
- NET SALES(Q) Lowest at USD 2.27 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -24.97%, its profits have fallen by -110.7%
- Promoters have decreased their stake in the company by -0.64% over the previous quarter and currently hold 15.37% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
- Along with generating -24.97% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wave Life Sciences Ltd. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At USD 40.52 MM has Grown at 126.69%
Higher at USD -95.44 MM
Highest at USD 1,035.19 MM
Highest at -98.57 %
Grown by 107.14% (YoY
Lowest at USD 2.27 MM
Lowest at USD -71.43 MM
Lowest at -3,144.06 %
Lowest at USD -69.36 MM
Lowest at USD -69.36 MM
Lowest at USD -0.34
Here's what is working for Wave Life Sciences Ltd.
Cash and Cash Equivalents
Depreciation (USD MM)
Here's what is not working for Wave Life Sciences Ltd.
Net Sales (USD MM)
Debt-Equity Ratio
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales






